Experience

Volastra Therapeutics

• United States
• Biotechnology
• 1 - 100 Employee

• Director, Biochemistry and Structural Biology

  • Jul 2022 - Present



Kadmon, a Sanofi Company

• United States
• Biotechnology Research
• 1 - 100 Employee

• Principal Scientist II, Lead of Structure Based Drug Design

  • Jan 2020 - Jul 2022

• Principal Scientist I, Lead of Structure Based Drug Design

  • Aug 2014 - Jan 2020



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Scientist

  • Nov 2012 - Aug 2014



Weill Medical College of Cornell University

• Postdoctoral Associate

  • Jan 2009 - Nov 2012

  Several lines of research linked to HIV-1 vaccine development Several lines of research linked to HIV-1 vaccine development



Skirball Institute of Biomolecular Medicine, New York University School of Medicine

• Ph.D. student

  • Mar 2002 - Dec 2008

  Structural and functional basis for the Grb14/10 inhibition of the insulin signaling pathway. Structural and functional basis for the Grb14/10 inhibition of the insulin signaling pathway.



New York University School of Medicine

• Research Assistant

  • Mar 2002 - Aug 2002

  Study of the HERG family of voltage dependent potassium channels. Study of the HERG family of voltage dependent potassium channels.



Wayne State University

• United States
• Higher Education
• 700 & Above Employee

• Visiting Student

  • Jun 2001 - Aug 2001

  Capacitanciometric and amperometric measurements of catecholamine exocytosis from bovine chromaffin cells in culture. Capacitanciometric and amperometric measurements of catecholamine exocytosis from bovine chromaffin cells in culture.



University of Buenos Aires

• Argentina
• Higher Education
• 700 & Above Employee

• TA

  • 1997 - 1997